FDA Approves Coartem Tablets to Treat Malaria
The U.S. Food and Drug Administration has approved Coartem tablets (artemether
and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least
five kilograms (approximately 11 pounds). Coartem is not approved for the treatment of severe malaria nor to prevent
malaria. Severe malaria is different than acute, uncomplicated malaria in that patients with severe malaria have altered
consciousness and other metabolic and end-organ complications. These patients are not candidates for oral drugs and
should be given intravenous anti-malarial therapy. Read more...
